These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation. Cook RC; Tupper JK; Parker S; Kingsbury K; Frohlich JJ; Abel JG; Gao M; Ignaszewski AP J Heart Lung Transplant; 1999 May; 18(5):420-4. PubMed ID: 10363685 [TBL] [Abstract][Full Text] [Related]
3. Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease. Giannetti N; Herity NA; Alimollah A; Gao SZ; Schroeder JS; Yeung AC; Hunt SA; Valantine HA Clin Transplant; 2001 Aug; 15(4):247-52. PubMed ID: 11683818 [TBL] [Abstract][Full Text] [Related]
6. Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure. Cook RC; Parker S; Kingsbury K; Frohlich JJ; Abel JG; Gao M; Ignaszewski AP J Heart Lung Transplant; 2001 Mar; 20(3):310-5. PubMed ID: 11257557 [TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia in organ transplantation. Sunder-Plassmann G; Floth A; Födinger M Curr Opin Urol; 2000 Mar; 10(2):87-94. PubMed ID: 10785848 [TBL] [Abstract][Full Text] [Related]
8. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. Booth GL; Wang EE CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726 [TBL] [Abstract][Full Text] [Related]